Back to Authors

Usmani, S. Z.

A5063057764 | I1334819555

Mayo Clinic

Memorial Sloan Kettering Cancer Center

Citations 3

P936: TIME TO RESPONSE, DURATION OF RESPONSE, AND PATIENT-REPORTED OUTCOMES WITH DARATUMUMAB PLUS RD VS RD ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NDMM: SUBGROUP ANALYSIS OF THE PHASE 3 MAIA STUDY

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 826-827

10.1097/01.hs9.0000846612.13339.9e

P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 851-852

10.1097/01.hs9.0000846712.74284.0f

B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

HemaSphere | April 6, 2022 | Volume: 6 | Issue: No issue available | Pages: 8-8

10.1097/01.hs9.0000829560.21894.ee